Although the concept of minimal residual disease (MRD) as an indicator for the quality of treatment response is the same in acute myeloid (AML) and acute lymphoid leukemia (ALL) the practice of measuring MRD levels for monitoring response and guiding post-induction therapy has been implemented much more rapidly in ALL particularly pediatric ALL than in… Continue reading Although the concept of minimal residual disease (MRD) as an indicator